Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3. This appears to be a minor version update to the page template.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's Locations list was updated with numerous additions and deletions across the United States, Canada, Europe, Australia, and Asia. This changes the study's geographic footprint and which sites are available to potential participants.SummaryDifference3%

- Check55 days agoChange DetectedThe Publications section now clarifies that entries are auto-filled from PubMed and shows updated revision labels (v3.3.2; v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding lapse notice that was displayed on the page; there are no changes to study content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedNo user-facing changes detected between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check106 days agoChange DetectedUpdated the page to v3.2.0 and added a government operating-status notice; removed the previous v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.